Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Assets (2020 - 2025)

Rapid Micro Biosystems' Current Assets history spans 6 years, with the latest figure at $60.1 million for Q2 2025.

  • For Q2 2025, Current Assets changed N/A year-over-year to $60.1 million; the TTM value through Jun 2025 reached $60.1 million, changed N/A, while the annual FY2024 figure was $80.9 million, 32.8% down from the prior year.
  • Current Assets for Q2 2025 was $60.1 million at Rapid Micro Biosystems, down from $80.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $244.2 million in Q3 2021 and bottomed at $60.1 million in Q2 2025.
  • The 5-year median for Current Assets is $135.7 million (2022), against an average of $147.2 million.
  • The largest annual shift saw Current Assets surged 250.96% in 2021 before it plummeted 36.47% in 2022.
  • A 5-year view of Current Assets shows it stood at $218.1 million in 2021, then tumbled by 36.47% to $138.6 million in 2022, then decreased by 13.11% to $120.4 million in 2023, then tumbled by 32.8% to $80.9 million in 2024, then dropped by 25.67% to $60.1 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Current Assets are $60.1 million (Q2 2025), $80.9 million (Q4 2024), and $120.4 million (Q4 2023).